Deubiquitinases cleave ubiquitin-fused ribosomal proteins and physically counteract their targeting to the UFD pathway
Molecular Cell · 2025
DOI: 10.1016/j.molcel.2025.10.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025. Verfasst von Stephanie Patchett und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA. Hauptthemen laut MEDLINE: Ribosomal Proteins, Ubiquitin, Deubiquitinating Enzymes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
In eukaryotes, each ribosomal subunit includes a ribosomal protein (RP) that is encoded as a fusion protein with ubiquitin (Ub). In yeast, each Ub-RP fusion requires processing by deubiquitylating enzymes (DUBs) to generate ribosome assembly-competent RPs and contribute to the cellular Ub pool. However, how Ub-RP fusions are processed by DUBs in human cells remains unclear. Here, we discovered that Ub-RPs are substrates of the Ub-fusion degradation (UFD) pathway in human cells via lysine 29 and 48 (K29/K48)-specific ubiquitylation and proteasomal degradation. We identified a pool of DUBs that catalytically process Ub-RPs, as well as DUBs that physically occlude Ub-RP interaction with UFD pathway Ub E3 ligases to prevent their degradation in a non-catalytic manner. Our results suggest that DUBs both process and stabilize Ub-RPs, whereas the UFD pathway regulates levels of Ub-RPs that cannot be fully processed by DUBs to fine-tune protein homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.
- Department of Biochemistry & Structural Biology and Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
- UbiQ Bio B.V., 1098 XH Amsterdam, the Netherlands.
- Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Proteomics Laboratory, Division of Advanced Research Technologies, New York University School of Medi…
- Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA. Electronic address: tony.huang@nyumc.org.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Patchett, S., Moghadasi, S. A., Shukla, A., El Oualid, F., Ueberheide, B. M., Olsen, S. K., & Huang, T. T. (2025). Deubiquitinases cleave ubiquitin-fused ribosomal proteins and physically counteract their targeting to the UFD pathway. Molecular Cell. https://doi.org/10.1016/j.molcel.2025.10.028
Vancouver
Patchett S, Moghadasi SA, Shukla A, El Oualid F, Ueberheide BM, Olsen SK, et al. Deubiquitinases cleave ubiquitin-fused ribosomal proteins and physically counteract their targeting to the UFD pathway. Molecular Cell. 2025. doi:10.1016/j.molcel.2025.10.028
BibTeX
@article{Patchett2025,
author = {Patchett, Stephanie and Moghadasi, Seyed Arad and Shukla, Ankita and El Oualid, Farid and Ueberheide, Beatrix M and Olsen, Shaun K and Huang, Tony T},
title = {Deubiquitinases cleave ubiquitin-fused ribosomal proteins and physically counteract their targeting to the UFD pathway},
journal = {Molecular Cell},
year = {2025},
doi = {10.1016/j.molcel.2025.10.028}
}
EUVIMED